SIEGALL CLAY B 4
4 · Immunome Inc. · Filed Nov 25, 2024
Insider Transaction Report
Form 4
Immunome Inc.IMNM
SIEGALL CLAY B
DirectorPresident and CEO
Transactions
- Purchase
Common Stock
2024-11-21$9.54/sh+66,057$630,263→ 485,693 total - Purchase
Common Stock
2024-11-22$9.78/sh+33,943$331,918→ 519,636 total
Footnotes (2)
- [F1]The weighted average purchase price for the transaction report was $9.5412, and the range of prices were between $9.41 and 9.68. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.
- [F2]The weighted average purchase price for the transaction report was $9.7787, and the range of prices were between $9.41 and $9.90. Upon request be the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price will be provided.